Retractable Technologies Bolsa (AMEX: RVP)

Retractable Technologies (AMEX:RVP) Bolsa

Retractable Technologies

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Retractable Technologies, Inc. Common Stock

Retractable Technologies Inc

Revolution Populi

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings, Inc. - Warrants

Retractable Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RVP#AMEX">RVP</a>) reported quarterly losses of $(0.35) per share. This is a 3600 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $8.30 million in sales this quarter. This is a 9.16 percent increase over sales of $7.60 million the same period last year.

Earnings

News

Retractable Technologies Q1 EPS $(0.35) Down From $0.01 YoY, Sales $8.30M Up From $7.60M YoY

General

Retractable Technologies Reduces Its Workforce By ~ 7%. The Reduction Is Expected To Save An Estimated $1.6M In Annual Wages And Benefits, Or Approximately 7.8% Of Total Estimated Workforce Costs

Retractable Technologies Q3 Sales $10.3M, Flat YoY

Retractable Technologies Files Complaint In U.S. Court Of International Trade To Challenge 100% Tariff On Syringes And Needles Imported From China, Seeking Injunctions And Tariff Reversal

The Dow Jones index closed lower by more than 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Neuronetics</h3>
<ul>
<li>The Trade: Neuronetics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) Director Glenn P Muir <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 25,000 shares</a> at an average price of $0.80. To acquire these shares, it cost around $20,000.</li>
<li>What's Happening: On Aug. 12, Neuronetics reported worse-than-expected second-quarter financial results and issued third-quarter revenue guidance below estimates.</li>
<li>What Neuronetics Does: Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.</li>
</ul>
<h3 class="wp-block-heading">ConnectM Technology Solutions</h3>
<ul>
<li>The Trade: ConnectM Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) Mahesh Choudhury &lt;a href=&#8221;https://www.benzinga.com/sec/insider-trades/&#8221;&gt;&lt;em&gt; acquired a total of 69,542 shares at &lt;/em&gt;&lt;/a&gt; at an average price of $0.89. To acquire these shares, it cost around $61,892.</li>
<li>What's Happening: On Aug. 13, ConnectM Technology Solutions posted a second-quarter loss of 39 cents per share.</li>
<li>What ConnectM Technology Solutions Does: ConnectM Technology Solutions Inc is a clean energy technology and solutions provider.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 5,251 shares</a> at an average price of $0.91. The insider spent around $4,799 to buy those shares.</li>
<li>What's Happening: On Aug. 14, Retractable Technologies posted a wider quarterly loss.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748893/over-40m-bet-on-pbf-energy-check-out-these-4-stocks-executives-are-buying">Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying</a></li>
</ul>

Penny Stocks

Markets

CNTM

STIM

Retractable Technologies And 2 Other Penny Stocks Executives Are Buying

The Dow Jones index closed lower by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 8,881 shares</a> at an average price of $0.94. To acquire these shares, it cost around $8,375.</li>
<li>What's Happening: On Aug. 14, Retractable Technologies posted a wider quarterly loss.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
<h3 class="wp-block-heading">Volcon</h3>
<ul>
<li>The Trade: Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) 10% owner Sabby Management, LLC <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 3,194 shares</a> at an average price of $1.55. To acquire these shares, it cost around $4,936.</li>
<li>What's Happening: On Aug. 6, Volcon reported a year-over-year increase in second-quarter sales results</li>
<li>What Volcon Does: Volcon Inc is an all-electric, off-road powersports vehicle company developing and building electric two and four-wheel motorcycles and utility terrain vehicles, also known as side-by-sides, along with a complete line of upgrades and accessories.</li>
</ul>
<h3 class="wp-block-heading">MSP Recovery</h3>
<ul>
<li>The Trade: MSP Recovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) CEO John Hasan Ruiz <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 50,000 shares</a> at an average price of $0.24. The insider spent around $12,115 to buy those shares.</li>
<li>What's Happening: On Aug. 18, MSP Recovery revealed a $3.1 million antitrust lawsuit settlement.</li>
<li>What MSP Recovery Does: MSP Recovery Inc is a healthcare recovery and data analytics company.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40600017/wall-streets-most-accurate-analysts-spotlight-on-3-materials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields</a></li>
</ul>

LIFW

VLCN

MSP Recovery And 2 Other Stocks Under $2 Executives Are Buying

Retractable Technologies (AMEX: RVP) reported quarterly losses of $(0.48) per share. This is a 269.23 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $6.03 million in sales this quarter. This is a 24.36 percent decrease over sales of $7.97 million the same period last year.

Retractable Technologies Q2 EPS $(0.48) Down From $(0.13) YoY, Sales $6.03M Down From $7.97M YoY

The Dow Jones index closed lower by over 500 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Super League Enterprise</h3>
<ul>
<li>The Trade: Super League Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) Director Jeff Patrick Gehl <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 50,000 shares at</a> an average price of $1.35. To acquire these shares, it cost around $67,548.</li>
<li>What's Happening: On June 21, Super League issued a mid-year update from the Company's Chief Executive Office, Ann Hand.</li>
<li>What Super League Enterprise Does: Super League Enterprise Inc is the rocket ship to the metaverse.</li>
</ul>
<h3 class="wp-block-heading">aTyr Pharma</h3>
<ul>
<li>The Trade: aTyr Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) Director Paul Schimmel <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 100,000 shares </a>at an average price of $1.85. To acquire these shares, it cost around $184,613.</li>
<li>What's Happening: On July 22, HC Wainwright &amp; Co. analyst Joseph Pantginis reiterated aTyr Pharma with a Buy rating and maintained a $35 price target.</li>
<li>What aTyr Pharma Does: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 8,788 shares</a> at an average price of $1.09. The insider spent around $9,579 to buy those shares. </li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39950906/nasdaq-s-p-500-record-worst-session-since-2022-amid-tesla-alphabet-selloff-investor-optimism-decrea">Nasdaq, S&amp;P 500 Record Worst Session Since 2022 Amid Tesla, Alphabet Selloff: Investor Optimism Decreases Further</a></li>
</ul>

Long Ideas

Insider Trades

Pre-Market Outlook

Trading Ideas

ATYR

Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed lower by more than 350 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Super League Enterprise</h3>
<ul>
<li>The Trade: Super League Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) Director Jeff Patrick Gehl <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 50,000 shares at </a>an average price of $1.11. To acquire these shares, it cost around $55,515.</li>
<li>What's Happening: On June 21, Super League issued a mid-year update from the Company&#8217;s Chief Executive Office, Ann Hand.</li>
<li>What Super League Enterprise Does: Super League Enterprise Inc is the rocket ship to the metaverse.</li>
</ul>
<h3 class="wp-block-heading">Wag! Group</h3>
<ul>
<li>The Trade: Wag! Group Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) 10% owner John P Szabo Jr <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 1,080,000 shares at </a>an average price of $1.39. To acquire these shares, it cost around $1.47 million.</li>
<li>What's Happening: On July 17, Wag! Group announced the pricing of an underwritten public offering of 7,407,407 shares of its common stock at $1.35 per share.</li>
<li>What Wag! Group Does: Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 12,710 shares</a> at an average price of $1.13. The insider spent around $14,352 to buy those shares. </li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39859170/top-3-industrials-stocks-that-may-rocket-higher-in-q3">Top 3 Industrials Stocks That May Rocket Higher In Q3</a></li>
</ul>

$1.5M Bet On This Tech Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying

The Dow Jones index closed lower by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 12,710 shares at</a> an average price of $1.13. To acquire these shares, it cost around $14,352.</li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
<h3 class="wp-block-heading">Pineapple Financial</h3>
<ul>
<li>The Trade: Pineapple Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#NYSE">PAPL</a>) Director, CEO Shubha Dasgupta <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 2,000 shares at</a> an average price of $0.97. To acquire these shares, it cost around $1,938.</li>
<li>What's Happening: On July 16, Pineapple Financial posted a third-quarter loss of 12 cents per share.</li>
<li>What Pineapple Financial Does: Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers.</li>
</ul>
<h3 class="wp-block-heading">Cyanotech</h3>
<ul>
<li>The Trade: Cyanotech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) Director Michael A / Davis <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 10,000 shares</a> at an average price of $0.58. The insider spent around $5,800 to buy those shares. </li>
<li>What's Happening: On June 26, Cyanotech reported net sales of $23,071,000 for fiscal 2024 compared to $23,178,000 in fiscal 2023.</li>
<li>What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39859847/netflix-to-rally-more-than-10-here-are-10-top-analyst-forecasts-for-friday">Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday</a></li>
</ul>

CYAN

PAPL

Pineapple Financial And 2 Other Stocks Under $5 Insiders Are Buying

The Dow Jones index closed lower by over 50 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Starco Brands</h3>
<ul>
<li>The Trade: Starco Brands, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/STCB#OTC">STCB</a>) CEO Ross Jeffery Sklar <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 28,000 shares</a> at an average price of $0.11. To acquire these shares, it cost around $2,992.</li>
<li>What's Happening: On July 9, Small Cap Consumer Research analyst Eric Beder reiterated Starco Brands with a Buy rating and maintained a $0.25 price target.</li>
<li>What Starco Brands Does: Starco Brands Inc is engaged in the direct response marketing of consumer products.</li>
</ul>
<h3 class="wp-block-heading">Douglas Elliman</h3>
<ul>
<li>The Trade: Douglas Elliman Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOUG#NYSE">DOUG</a>) Executive Vice President &amp; COO Richard Lampen <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 155,000 shares at</a> an average price of $1.09. To acquire these shares, it cost around $169,461.</li>
<li>What's Happening: On July 2, Douglas Elliman announced that it secured a $50 million growth investment from Kennedy Lewis Investment Management.</li>
<li>What Douglas Elliman Does: Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) CEO and President Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 8,411 shares</a> at an average price of $1.12. The insider spent around $9,420 to buy those shares. 
What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.
What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39690602/delta-air-lines-likely-to-report-lower-q2-earnings-here-are-the-recent-forecast-changes-from-wall-s">Delta Air Lines Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

DOUG

STCB

Douglas Elliman And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed lower by around 0.1% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Rekor Systems</h3>
<ul>
<li>The Trade: Rekor Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) 10% owner Arctis Global LLC <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 2,275,000 shares</a> at an average price of $1.40. To acquire these shares, it cost around $3.19 million.</li>
<li>What's Happening: On May 20, Rekor Systems announced a partnership with MS2.</li>
<li>What Rekor Systems Does: Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions.</li>
</ul>
<h3 class="wp-block-heading">System1</h3>
<ul>
<li>The Trade: System1, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) 10% owner CEE Holdings Trust <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 2,603 shares at </a>&lt;/em&gt;&lt;/a&gt; at an average price of $1.45. To acquire these shares, it cost around $3,774.</li>
<li>What's Happening: On May 9, System1 posted upbeat first-quarter results.</li>
<li>What System1 Does: System1 Inc develops technology and data science to operate a responsive acquisition marketing platform.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) CEO and President Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 8,788 shares</a> at an average price of $1.14. The insider spent around $10,018 to buy those shares. </li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39665755/wall-streets-most-accurate-analysts-say-buy-these-3-utilities-stocks-delivering-high-div">Wall Street&#8217;s Most Accurate Analysts Say Buy These 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

REKR

Over $3M Bet On This Tech Stock? Check Out These 3 Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones index closed slightly higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Crexendo</h3>
<ul>
<li>The Trade: Crexendo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) Chief Revenue Officer Jon Brinton <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,000 shares</a> at an average price of $3.51. To acquire these shares, it cost around $3,510.</li>
<li>What's Happening: On May 7, Crexendo posted upbeat quarterly results.</li>
<li>What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 32,752 shares</a> at an average price of $0.88. To acquire these shares, it cost around $28,884.</li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/39006627/top-3-materials-stocks-that-are-set-to-fly-this-quarter">Top 3 Materials Stocks That Are Set To Fly This Quarter</a>
<h3 class="wp-block-heading">Aurora Innovation</h3>
<ul>
<li>The Trade: Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) 10% owner Uber Technologies, Inc <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 25,037,036 shares</a> at an average price of $3.00. The insider spent around $75 million to buy those shares. </li>
<li>What's Happening: On May 8, Aurora Innovation reported a narrower-than-expected first-quarter loss.</li>
<li>What Aurora Innovation Does: Aurora Innovation Inc is engaged in delivering self-driving technology safely, quickly, and broadly.</li>
</ul>
<h3 class="wp-block-heading">Telos</h3>
<ul>
<li>The Trade: Telos Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) Director Fredrick Schaufeld <a href="https://www.benzinga.com/quote/TLS/analyst-ratings">acquired a total of 54,650 shares</a> at an average price of $3.98. The insider spent around $217,507 to buy those shares.</li>
<li>What's Happening: On May 10, Telos posted upbeat quarterly results.</li>
<li>What Telos Does: Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world&#8217;s security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats.</li>
</ul>
<h3 class="wp-block-heading">Nanophase Technologies</h3>
<ul>
<li>The Trade: Nanophase Technologies Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NANX#OTC">NANX</a>) Director R Janet Whitmore <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 19,040 shares</a> at an average price of $1.36. The insider spent $25,962 to buy those shares.</li>
<li>What's Happening: On April 23, Nanophase Technologies announced financial results for the first quarter ended March 31, 2024.</li>
<li>What Nanophase Technologies Does: Nanophase Technologies Corp is engaged in the production of engineered nanomaterial solutions and larger, sub-micron, materials such as personal care sunscreens, architectural coatings, industrial coating applications, and abrasion-resistant additives, plastics additives, medical diagnostics, energy.</li>
</ul>
Don&#8217;t forget to check out our p<a href="https://www.benzinga.com/premarket/">remarket coverage here</a>

CXDO

NANX

$75M Bet On Aurora Innovation? Check Out These 5 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed lower by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,210 shares</a> at an average price of $1.12. To acquire these shares, it cost around $1,355.</li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
<h3 class="wp-block-heading">Marchex</h3>
<ul>
<li>The Trade: Marchex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) CEO Edwin A Miller <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 7,723 shares at</a> an average price of $1.40. To acquire these shares, it cost around $10,803.</li>
<li>What's Happening: On May 7, Marchex posted downbeat quarterly sales.</li>
<li>What Marchex Does: Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business.</li>
</ul>
<h3 class="wp-block-heading">Reneo Pharmaceuticals</h3>
<ul>
<li>The Trade: Reneo Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPHM#NASDAQ">RPHM</a>) 10% owner Braden Michael Leonard <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 414,281 shares</a> at an average price of $1.54. The insider spent around $639,578 to buy those shares.</li>
<li>What's Happening: On May 13, Reneo Pharmaceuticals entered into a merger agreement with OnKure.</li>
<li>What Reneo Pharmaceuticals Does: Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38872018/top-5-utilities-stocks-you-may-want-to-dump-in-may">Top 5 Utilities Stocks You May Want To Dump In May</a>

MCHX

RPHM

Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying

Retractable Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RVP#AMEX">RVP</a>) reported quarterly earnings of $0.01 per share. This is a 66.67 percent decrease over earnings of $0.03 per share from the same period last year. The company reported $7.60 million in sales this quarter. This is a 30.92 percent decrease over sales of $11.00 million the same period last year.

Retractable Technologies Q1 EPS $0.01 Down From $0.03 YoY, Sales $7.60M Down From $11.00M YoY

The Dow Jones index closed higher by around 0.1% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 4,240 shares</a> at an average price of $1.09. To acquire these shares, it cost around $4,622.</li>
<li>What's Happening: On March 29, Retractable Technologies reported results for 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
<h3 class="wp-block-heading">Earth Science Tech</h3>
<ul>
<li>The Trade: Earth Science Tech, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ETST#OTC">ETST</a>) CEO Giorgio R. Saumat <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 20,000 shares at</a> an average price of $0.10. To acquire these shares, it cost around $1,900.</li>
<li>What's Happening: On Jan. 29, Earth Science Tech announced a $5 million common stock repurchase program.</li>
<li>What Earth Science Tech Does: Earth Science Tech Inc is a diversified holding company. Currently, the company is focused on emerging prospects in the health and wellness industry.</li>
</ul>
<h3 class="wp-block-heading">GrafTech International</h3>
<ul>
<li>The Trade: GrafTech International Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) 10% owner WJS Investments Ltd <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 163,250 shares</a> at an average price of $1.81. The insider spent around $295,433 to buy those shares.</li>
<li>What's Happening: On April 26, GrafTech International reported better-than-expected first-quarter financial results.</li>
<li>What GrafTech International Does: GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/05/38694011/flywire-reports-q1-loss-joins-zoominfo-inspire-medical-systems-and-other-big-stocks-moving-lower-in">Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday&#8217;s Pre-Market Session</a>

ETST

GrafTech International And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by around 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">GrafTech International</h3>
<ul>
<li>The Trade: GrafTech International Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) 10% owner WJS Investments Ltd <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 179,279 shares</a> at an average price of $1.48. To acquire these shares, it cost around $266,211.</li>
<li>What's Happening: On April 26, GrafTech International reported better-than-expected first-quarter financial results.</li>
<li>What GrafTech International Does: GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals.</li>
</ul>
<h3 class="wp-block-heading">Expensify</h3>
<ul>
<li>The Trade: Expensify, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) 10% owner SF Roofdeck GP LLC <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 17,711 shares</a> at an average price of $1.59. To acquire these shares, it cost around $28,162.</li>
<li>What's Happening: Expensify is expected to announce first-quarter financial results after market close on Thursday, May 9.</li>
<li>What Expensify Does: Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money.</li>
</ul>
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 872 shares</a> at an average price of $1.07. The insider spent around $932 to buy those shares.</li>
<li>What's Happening: On March 29, Retractable Technologies reported results for 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38510121/investor-sentiment-improves-further-dow-jumps-over-100-points">Investor Sentiment Improves Further, Dow Jumps Over 100 Points</a>

EXFY

GrafTech International And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by more than 50 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Global Crossing Airlines Group </h3>
<ul>
<li>The Trade: Global Crossing Airlines Group Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/jetmf#OTC">JETMF</a>) 10% owner Red Oak Partners, LLC<a href="https://www.benzinga.com/quote/JETMF/analyst-ratings"> acquired a total of 722,581 shares </a> an average price of $0.38. To acquire these shares, it cost around $274,581.</li>
<li>What&rsquo;s Happening: On April 3, Global Crossing Airlines Group said it has been approved by the US Department of Transportation for an increase to 20 aircraft from its current authorization of 16 aircraft.</li>
<li>What Global Crossing Airlines Group Does: Global Crossing Airlines Group Inc is an airline operator for both narrow and widebody aircraft around the world, utilizing the efficiencies of an Airbus A320/321 fleet.</li>
</ul>
<h3>Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvp#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 3,587 shares at </a> at an average price of $1.06. To acquire these shares, it cost around $3,802.</li>
<li>What&rsquo;s Happening: On March 29, Retractable Technologies reported results for 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38285179/travelers-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-street"> Travelers Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts </a>
<h3>RENN Fund </h3>
<ul>
<li>The Trade: RENN Fund, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcg#NYSE">RCG</a>) President and CEO Murray Stahl <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 57 shares </a> at an average price of $1.65. The insider spent around $94 to buy those shares.</li>
<li>What&rsquo;s Happening: RENN Fund shares fell around 10% over the past six months.</li>
<li>What RENN Fund Does: RENN Fund Inc is active in the financial services domain. It is a closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

JETMF

Retractable Technologies And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Aldeyra Therapeutics </h3>
<ul>
<li>The Trade: Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) 10% owner Joseph Edelman <a href="https://www.benzinga.com/quote/CALC/analyst-ratings"> acquired a total of 504,272 shares </a> an average price of $3.84. To acquire these shares, it cost around $1.93 million.</li>
<li>What&rsquo;s Happening: On April 3, Oppenheimer upgraded the stock from Perform to Outperform and announced a $10 price target.</li>
<li>What Aldeyra Therapeutics Does: Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases.</li>
</ul>
<h3>Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvp#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 8,292 shares at </a> at an average price of $1.15. To acquire these shares, it cost around $9,499.</li>
<li>What&rsquo;s Happening: On March 29, Retractable Technologies reported results for 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38084045/levi-strauss-conagra-brands-and-3-stocks-to-watch-heading-into-thursday"> Levi Strauss, Conagra Brands And 3 Stocks To Watch Heading Into Thursday </a>
<h3>Alzamend Neuro </h3>
<ul>
<li>The Trade: Alzamend Neuro, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alzn#NASDAQ">ALZN</a>) Director Milton C Ault III <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 334 shares </a> at an average price of $0.91. The insider spent around $304 to buy those shares.</li>
<li>What&rsquo;s Happening: On Dec. 11, 2023, Alzamend Neuro received a &quot;Study May Proceed&quot; letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for post-traumatic stress disorder (PTSD).</li>
<li>What Alzamend Neuro Does: Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer&#39;s.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

ALDX

ALZN

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Retractable Technologies </h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvp#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/quote/RVP/analyst-ratings"> acquired a total of 5,096 shares </a> an average price of $1.18. To acquire these shares, it cost around $6,024.</li>
<li>What&rsquo;s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
<h3>Citizens</h3>
<ul>
<li>The Trade: Citizens, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cia#NYSE">CIA</a>) Director James Keith Morgan <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 5,899 shares at </a> at an average price of $2.11. To acquire these shares, it cost around $12,469.</li>
<li>What&rsquo;s Happening: On March 18, Citizens, named Jon Stenberg as President of Citizens.</li>
<li>What Citizens Does: Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/03/37975793/walgreens-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-cal"> Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call </a>
<h3>Journey Medical </h3>
<ul>
<li>The Trade: Journey Medical Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) Director Lindsay A MD Rosenwald <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $3.04. The insider spent around $30,400 to buy those shares.</li>
<li>What&rsquo;s Happening: On March 21, Journey Medical posted a profit for the fourth quarter.</li>
<li>What Journey Medical Does: Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Comments

Retractable Technologies

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL